TOSSI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 18.406
EU - Europa 8.684
AS - Asia 7.703
SA - Sud America 934
Continente sconosciuto - Info sul continente non disponibili 765
AF - Africa 219
OC - Oceania 28
Totale 36.739
Nazione #
US - Stati Uniti d'America 18.173
SG - Singapore 2.700
CN - Cina 2.029
PL - Polonia 1.692
IT - Italia 1.460
SE - Svezia 1.265
UA - Ucraina 933
DE - Germania 800
BR - Brasile 724
VN - Vietnam 708
HK - Hong Kong 656
FR - Francia 487
FI - Finlandia 475
KR - Corea 418
GB - Regno Unito 417
TR - Turchia 342
RU - Federazione Russa 278
BD - Bangladesh 239
IN - India 199
BG - Bulgaria 165
IE - Irlanda 163
NL - Olanda 143
CA - Canada 112
MA - Marocco 74
JP - Giappone 69
BE - Belgio 64
MX - Messico 59
CH - Svizzera 58
AR - Argentina 56
ES - Italia 50
ZA - Sudafrica 48
IQ - Iraq 47
BY - Bielorussia 43
PK - Pakistan 43
EC - Ecuador 38
HR - Croazia 35
AT - Austria 27
PH - Filippine 27
CZ - Repubblica Ceca 26
SN - Senegal 26
CO - Colombia 25
UZ - Uzbekistan 23
CL - Cile 22
SA - Arabia Saudita 22
ID - Indonesia 21
VE - Venezuela 21
PE - Perù 20
AZ - Azerbaigian 18
MY - Malesia 17
RO - Romania 17
PT - Portogallo 16
AU - Australia 15
EU - Europa 15
CR - Costa Rica 14
JM - Giamaica 14
KE - Kenya 14
JO - Giordania 13
NZ - Nuova Zelanda 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
IR - Iran 12
TH - Thailandia 12
DZ - Algeria 11
EG - Egitto 10
GR - Grecia 10
TW - Taiwan 10
NP - Nepal 9
UY - Uruguay 9
LT - Lituania 8
RS - Serbia 8
DK - Danimarca 7
KZ - Kazakistan 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
GE - Georgia 6
HU - Ungheria 6
OM - Oman 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BO - Bolivia 5
NG - Nigeria 5
NI - Nicaragua 5
TN - Tunisia 5
AL - Albania 4
BH - Bahrain 4
KG - Kirghizistan 4
LV - Lettonia 4
MD - Moldavia 4
NO - Norvegia 4
PR - Porto Rico 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BS - Bahamas 3
CI - Costa d'Avorio 3
GA - Gabon 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
SY - Repubblica araba siriana 3
CG - Congo 2
Totale 35.953
Città #
Ashburn 1.823
Ann Arbor 1.795
Singapore 1.684
Woodbridge 1.655
Warsaw 1.514
Houston 1.411
Fairfield 1.406
Chandler 1.103
Jacksonville 818
San Jose 793
Wilmington 715
Hong Kong 629
Seattle 574
Beijing 498
Cambridge 487
Hefei 448
Trieste 433
Seoul 405
Council Bluffs 339
Boardman 322
Princeton 319
Izmir 297
Columbus 266
Los Angeles 265
Chicago 246
Dallas 202
Ho Chi Minh City 194
Dearborn 182
Munich 177
Lauterbourg 175
Dublin 162
Sofia 162
Hanoi 160
Milan 155
Helsinki 153
Santa Clara 150
Zgierz 145
Buffalo 132
The Dalles 131
Moscow 120
Frankfurt am Main 112
New York 104
Düsseldorf 92
San Diego 90
São Paulo 79
London 71
Casablanca 63
Falls Church 60
Phoenix 58
Brussels 57
Tokyo 54
Nanjing 51
Verona 51
Amsterdam 46
Des Moines 46
Shanghai 45
Orem 42
Turku 41
Redwood City 40
Rome 39
Guangzhou 38
Toronto 38
Bern 35
Chennai 35
Kunming 35
Miano 35
Porto Alegre 35
San Francisco 35
Brooklyn 33
Bremen 30
Denver 29
Jinan 28
Sacile 28
Da Nang 27
Montreal 27
Dakar 26
Haiphong 26
Johannesburg 26
Pune 26
Stockholm 26
Washington 26
Norwalk 25
Dong Ket 24
Roubaix 24
Tianjin 24
Mumbai 23
Rio de Janeiro 23
Shenyang 23
Atlanta 20
Brno 20
Changsha 20
Manchester 20
Mestre 20
Vienna 20
Baghdad 19
Hangzhou 19
Baku 18
Nuremberg 18
Redondo Beach 18
Tashkent 18
Totale 24.926
Nome #
Biofilms from Klebsiella pneumoniae: Matrix Polysaccharide Structure and Interactions with Antimicrobial Peptides 523
Effects of gold nanoparticles, protected by self-assembling mixtures of ligands, on eukaryotic cells and model membranes 478
Antibacterial activity of Bac7(1-35) and BMAP-27 against biofilm-embedded A. baumannii 438
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine 422
Myticalins: A novel multigenic family of linear, cationic antimicrobial peptides from marine mussels (Mytilus spp.) 385
Insights on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 384
Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives 369
A study of some ruthenium polypyridyl complexes as DNA binders and photocleavage reagents 361
Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7 346
Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing 345
New consensus hydrophobicity scale extended to non-proteinogenic amino acids 339
The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator 335
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 320
Parallel identification of novel antimicrobial peptide sequences from multiple anuran species by targeted DNA sequencing 320
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. 316
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 307
Alpha-helical antimicrobial peptides-Using a sequence template to guide structure-activity relationship studies 302
Mixed Fluorinated/Hydrogenated Self-Assembled Monolayer-Protected Gold Nanoparticles: In Silico and In Vitro Behavior 295
Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. 291
Amphipathic alpha helical antimicrobial peptides: A systematic study of the effects of structural and physical properties on biological activity. 291
Histatins In Non-Human Primates: Gene Variations and Functional Effects. 289
An appraoch combining rapid cDNA amplification and chemical synthesis for the identification of novel, cathelicidin-derived, antimicrobial peptides. 288
Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption 287
A synthetic approach for a SAR study of the Pro- and Arg-rich bactenecin bac7. 282
The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome 282
A Novel [60]Fullerene Amino Acid for Use in Solid Phase Peptide Synthesis 279
Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. 276
Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization 274
Structural and Functional Diversity of Cathelicidins 273
An approach combining rapid cDNA amplification and chemical synthesis for the identification of novel, cathelicidin-derived, antimicrobial peptides. 266
Antibacterial activity affected by the conformational flexibility in glycine-lysine-based α-helical antimicrobial peptides 266
Synthesis and Biological Activity of Potent HIV-1 Protease Inhibitors Based on Phe-Pro Dihydroxyethylene Isosteres 264
Small hydroxyethylene-based peptidomimetics inhibiting both HIV-1 and C. albicans aspartic protease 262
Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852) 262
Broad spectrum activity against bacterial mastitis pathogens and activation of mammary epithelial cells support a protective role of neutrophil cathelicidins in bovine mastitis 259
Computational design of highly selective antimicrobial peptides. 257
Design of new inhibitors of HIV-1 aspartic protease 257
Techniques for plant defensin production. 257
A study of the interactions of some polypyridylruthenium(II) complexes with DNA using fluorescence spectroscopy, topoisomerisation and thermal denaturation 254
Primate beta-defensins--structure, function and evolution. 252
Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin 251
Influence of bacterial biofilm polysaccharide structure on interactions with antimicrobial peptides: A study on klebsiella pneumoniae 247
Synthetic antimicrobial peptides designed from sequence templates 246
Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37 246
Cellular Internalization and Cytotoxicity of the Antimicrobial Proline-rich Peptide Bac7(1-35) in Monocytes/Macrophages, and its Activity Against Phagocytosed Salmonella Typhimurium 245
Multivalent, mixed self-assembled monolayer protected gold nanoparticles: from design to biological application 245
Comparative activity and mechanism of action of three types of bovine antimicrobial peptides against pathogenic Prototheca spp. 245
PMAP-37, a novel antibacterial peptide from pig myeloid cells: c-DNA cloning, chemical synthesis and activity 244
Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL-37 244
A study of host defence peptide beta-defensin 3 in primates. 243
Structure dependence of biological activities for primate cathelicidins. 242
Solid-phase synthesis of fullerene-peptides. 241
Wide-spectrum antibiotic activity of synthetic, amphipathic peptides 240
Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins 240
Effect of structural and chemico-physical factors on the biological activity of linear antimicrobial peptides 238
Inibitori peptidomimetici di HIV-PR basati su isosteri diamminodiolici del dipeptide Phe-Pro 237
Designing short peptides with high affinity for organic molecules: a combined docking, molecular dynamics and Monte Carlo approach 235
Defensins 235
Computational and experimental investigation on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 235
Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides 234
Amphipathic, alpha-helical antimicrobial peptides. 233
Binding of Ru(bpy)32+ and Ru(phen)32+ to polynucleotides and DNA. Effect of added salts on the absorption and luminescence properties 232
Design of antimicrobial peptides based on sequence analogy and amphipathicity 229
Evolution of the beta-defensin 2 gene in higher primates 229
The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner 227
Role of Cathelicidin Peptides in Bovine Host Defense and Healing 227
Structural aspects of plant antimicrobial peptides 227
Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical "sequence template" 225
Evolution of the hepcidin gene in primates. 225
Flexible synthesis of symmetric and non-symmetric hiv-1 protease inhibitors based on all-s-diaminodiol isosteres 224
A computational study of the resistance of HIV-1 aspartic protease to the inhibitors ABT-538 and VX-478 and design of new analogs 223
Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells 222
Primate cathelicidin orthologues display different structures and membrane interactions 219
Development of pseudopeptide inhibitors of HIV-1 aspartic protease: analysis and tuning of the subsite specificity 217
Splitting the blosum score into numbers of biological significance. 216
Topical anti-inflammatory activity of Plantago major L. leaves 214
Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity 213
Cationic Antimicrobial Peptides—The Defensins 212
Synthetic approach to the identification of the antibacterial domain of bactenecins, Pro/Arg rich peptides from bovine neutrophils. 210
Structure Based Design of Inhibitors of Aspartic Protease of HIV-1 210
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity 210
Proline-rich Antimicrobial Peptides: Converging to a Non-Lytic Mechanism of Action. 208
Aspartic protease inhibitors. An integrated approach for the design and synthesis of diaminodiol based peptidomimetics 207
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts 206
Effects on APC antigen presenting cells of short-term interaction with the human human host defense peptide beta-defensin 2 206
Photo-induced electron transfer from nucleotides to ruthenium-tris-1,4,5,8 tetraazaphenanthrene: model for photosensitized DNA oxidation 205
Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. 202
Site-specific photocleavage of DNA 202
Mammalian Defensins: Structures and Mechanism of Antibiotic Activity 202
Beta-defensin 2 in the rhesus monkey (Macaca mulatta) and the long-tailed macaque (M. fascicularis) 201
Localization of beta-defensin genes in non human primates 200
Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. 200
Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions. 200
The Non-Peptidic HIV Protease Inhibitor Tipranavir and Two Synthetic Peptidomimetics (TS98 and TS102) Modulate Pneumocystis carinii Growth and Proteasome Activity of HEL299 Cell Line 199
Versatile and stereoselective synthesis of diamino diol dipeptide isosteres, core units of pseudopeptide HIV protease inhibitors 198
Anti-inflammatory activity of Sea Buckthorn (Hippophae rhamnoides L.) 198
ChBac3.4: A novel proline-rich antimicrobial peptide from goat leukocytes 197
Characterization of a new defensin from cowpea (Vigna unguiculata (L.) Walp.). 197
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 196
Structural aspects and biological properties of the cathelicidin PMAP-36 196
Totale 25.850
Categoria #
all - tutte 100.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.101 0 0 132 252 57 196 84 75 254 254 205 592
2022/20232.962 291 398 219 502 252 542 14 238 334 16 110 46
2023/20241.475 102 103 97 112 158 140 220 310 21 27 111 74
2024/20253.872 39 88 270 373 390 370 349 230 524 425 378 436
2025/20269.816 926 586 767 850 824 844 1.443 339 1.044 1.369 464 360
2026/20271.262 345 521 396 0 0 0 0 0 0 0 0 0
Totale 36.739